Top movers in Friday's pre-market session
By Mill Chart
Last update: Mar 22, 2024
Curious about the stocks that are showing activity before the opening bell on Friday?
Today's pre-market gainers
| Ticker | Change | Comment |
|---|---|---|
| BCAN | 13.0K% | BYND CANNASOFT ENTERPRISES (NASDAQ:BCAN) recorded a 13.0K% increase in share price during the pre-market session, reaching $2.48 on Friday. Shareholders saw the stock price going 90.54% lower in the past month. |
| MBRX | 1.0K% | MOLECULIN BIOTECH INC (NASDAQ:MBRX) recorded a 1.0K% increase in share price during the pre-market session, reaching $5.9 on Friday. The stock is trading 35.0% lower than 3 months ago. |
| MLGO | 1.0K% | Investors witnessed a remarkable surge in MICROALGO INC (NASDAQ:MLGO) during Friday's pre-market session, with the stock price rising 1.0K% to $5.09. In the last month the stock lost 44.81%. |
| ATER | 1.0K% | The pre-market session on Friday saw a significant rise in ATERIAN INC's (NASDAQ:ATER) shares, climbing 1.0K% to $3.0. Shareholders saw the stock price going 26.77% lower in the past month. |
| BIOL | 62.33% | BIOLASE INC (NASDAQ:BIOL) experienced an impressive 62.33% increase in share price, reaching $0.24 during the pre-market session on Friday. Shareholders saw the stock price going 87.07% lower in the past 3 months. |
| OTLK | 44.74% | Investors witnessed a remarkable surge in OUTLOOK THERAPEUTICS INC (NASDAQ:OTLK) during Friday's pre-market session, with the stock price rising 44.74% to $10.19. In the last 6 months the stock gained 68.5%. |
| FFIE | 29.41% | FARADAY FUTURE INTELLIGENT E (NASDAQ:FFIE) rose 29.41% to $0.18 during Friday's pre-market session. Yesterday's 48.63% gain sets the stage for a strong start in today's pre-market session, as NASDAQ:FFIE shows a 29.41% increase. |
| FRSX | 26.54% | Exciting news for FORESIGHT AUTONOMOUS-SP ADR (NASDAQ:FRSX) as their shares soared 26.54% to $1.24 during the pre-market session on Friday. In the last 6 months the share price dropped with 56.25%. |
| CCG | 19.86% | Investors witnessed a remarkable surge in CHECHE GROUP INC (NASDAQ:CCG) during Friday's pre-market session, with the stock price rising 19.86% to $5.07. The stock is trading 33.8% lower than 3 months ago. |
| ANGH | 17.13% | Exciting news for ANGHAMI INC (NASDAQ:ANGH) as their shares soared 17.13% to $2.12 during the pre-market session on Friday. This is a continuation of yesterday's gain of 13.84%. |
To see the full list of premarket gainers you can use our premarket gainers page.
Pre-market losers
| Ticker | Change | Comment |
|---|---|---|
| SINT | -34.04% | The stock price of SINTX TECHNOLOGIES INC (NASDAQ:SINT) is declining by 34.04%, reaching $0.09 during Friday's pre-market session. In the last 3 months the stock lost 71.06%. |
| ABTS | -14.96% | The stock price of ABITS GROUP INC (NASDAQ:ABTS) is experiencing a decline of 14.96%, reaching $0.66 in today's pre-market session on Friday. The stock is trading 21.21% lower than a month ago. |
| LULU | -13.1% | The pre-market session on Friday witnessed a 13.1% decrease in LULULEMON ATHLETICA INC's (NASDAQ:LULU) shares, with the stock price falling to $416.09. The stock is trading 23.4% higher than 6 months ago. |
| CUTR | -13.04% | CUTERA INC's (NASDAQ:CUTR) stock price decreased by 13.04% to $2.0. A press release (Cutera Announces Fourth Quarter and Full-Year 2023 Financial Results Along with 2024 Outlook) was released yesterday. |
| JOAN | -12.99% | JOANN INC's (NASDAQ:JOAN) stock price is declining with 12.99% to a price of $0.13. Following yesterday's gain of 14.07%, NASDAQ:JOAN experiences a 12.99% decrease in today's pre-market session, indicating a pullback from the previous session's performance. |
| GNS | -10.36% | GENIUS GROUP LTD's (NYSEARCA:GNS) shares fell 10.36% to $0.47. In the last month the share price increased with 51.25%. |
| YTEN | -10.17% | The stock price of YIELD10 BIOSCIENCE INC (NASDAQ:YTEN) is declining by 10.17%, reaching $0.39 during Friday's pre-market session. The current market conditions exhibit high volatility as NASDAQ:YTEN retraces its steps after yesterday's 78.85% gain. A press release (USDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United States) was released yesterday. |
| ASST | -10.06% | Today's pre-market session reveals a 10.06% decline in the stock price of ASSET ENTITIES INC-B (NASDAQ:ASST), now priced at $0.58. Following yesterday's notable 27.72% increase, NASDAQ:ASST undergoes a 10.06% decrease in today's pre-market session, suggesting a temporary pullback. A press release (Asset Entities Inc. Enters Into Agreement with Zendrop, the “#1 High Margin Dropshipping App”) was released yesterday. |
| TBIO | -9.81% | Friday's pre-market session showed a 9.81% decrease in the stock price of TELESIS BIO INC (NASDAQ:TBIO), reaching $0.42. In the last 6 months the share price dropped with 61.19%. |
| GRFS | -9.65% | GRIFOLS SA-ADR's (NASDAQ:GRFS) stock price decreased by 9.65% to $6.13. Shareholders saw the stock price going 22.07% lower in the past month. |
For the full premarket loser list go to our premarket losers page.
OUTLOOK THERAPEUTICS INC
NASDAQ:OTLK (4/26/2024, 7:08:27 PM)
After market: 8.31 -0.12 (-1.42%)8.43
+0.24 (+2.93%)
OTLK News
ISELIN, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first...
13 days ago - InvestorPlaceBiotech on a Budget: 7 Stocks Under $10 With Huge PotentialWith the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks.
Positive opinion serves as a basis for final decision for potential authorization from the European Commission (EC), expected within 67 days ISELIN, N.J.,...
ISELIN, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment of retinal diseases in the US and the EU, today announced that it has closed its previously announced private placement, for upfront gross proceeds of approximately $60 million from the issuance and sale of shares of the Company’s common stock and accompanying warrants, before deducting placement agent fees and offering expenses. Outlook Therapeutics has the potential to receive additional gross proceeds of up to $99 million upon the full cash exercise of the warrants issued in the private placement, before deducting placement agent fees and offering expenses.
ISELIN, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the “Company”), a biopharmaceutical company working to...
2 months ago - InvestorPlace7 of the Best Speculative Stocks You Can Snag for Less Than $1Although speculative stocks under $1 are by their very nature extremely risky, these ideas might have enough to go the distance.
2 months ago - InvestorPlace7 Biotech Penny Stocks on the Verge of Clinical Trial VictoryBiotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.
2 months ago - Seeking AlphaOutlook Therapeutics stock climbs 13% amid Chardan upgrade (NASDAQ:OTLK)Shares of Outlook Therapeutics (OTLK) climbed 13% after Chardan upgraded the stock to buy, citing the company’s recent private placement and the full cash exerc
NORSE EIGHT underway with first subject dosed and additional clinical sites beginning enrollment Continue to expect planned resubmission of the ONS-5010...
NORSE EIGHT clinical trial is being conducted under Special Protocol Assessment (SPA) from FDA to support expected resubmission of the ONS-5010 Biologics...
